These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7994508)

  • 21. The effects of gabapentin on methadone based addiction treatment: a randomized controlled trial.
    Moghadam MS; Alavinia M
    Pak J Pharm Sci; 2013 Sep; 26(5):985-9. PubMed ID: 24035957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.
    Schmittner J; Schroeder JR; Epstein DH; Krantz MJ; Eid NC; Preston KL
    Pharmacotherapy; 2009 May; 29(5):495-502. PubMed ID: 19397459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care-based ambulatory opioid detoxification: the results of a clinical trial.
    O'Connor PG; Waugh ME; Carroll KM; Rounsaville BJ; Diagkogiannis IA; Schottenfeld RS
    J Gen Intern Med; 1995 May; 10(5):255-60. PubMed ID: 7616334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification.
    Amass L; Bickel WK; Higgins ST; Hughes JR
    J Addict Dis; 1994; 13(3):33-45. PubMed ID: 7734458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid detoxification in pregnancy.
    Dashe JS; Jackson GL; Olscher DA; Zane EH; Wendel GD
    Obstet Gynecol; 1998 Nov; 92(5):854-8. PubMed ID: 9794682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.
    Lee SY; Chen SL; Chang YH; Chu CH; Chen SH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv008. PubMed ID: 25716777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [High-dose methadone detoxification in a hospital unit. Clinical experience].
    Ochoa E; Salvador E; Madoz-Gúrpide A; Lázaro M
    Adicciones; 2008; 20(3):245-9. PubMed ID: 18813771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2001; (1):CD002024. PubMed ID: 11279747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study.
    Uhde TW; Redmond DE; Kleber HD
    Psychiatry Res; 1980 Mar; 2(1):37-47. PubMed ID: 6932053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department.
    Klein LR; Cole JB; Driver BE; Miner JR; Laes JR; Fagerstrom E; L Martel M
    Clin Toxicol (Phila); 2019 Aug; 57(8):697-702. PubMed ID: 30712404
    [No Abstract]   [Full Text] [Related]  

  • 32. Organic mood syndrome associated with detoxification from methadone maintenance.
    Kanof PD; Aronson MJ; Ness R
    Am J Psychiatry; 1993 Mar; 150(3):423-8. PubMed ID: 8434657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.
    San L; Fernandez T; Cami J; Gossop M
    J Subst Abuse Treat; 1994; 11(5):463-9. PubMed ID: 7869468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
    Strain EC; Bigelow GE; Liebson IA; Stitzer ML
    JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
    Azatian A; Papiasvilli A; Joseph H
    J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal.
    Lin SK; Pan CH; Chen CH
    J Clin Psychopharmacol; 2014 Aug; 34(4):508-12. PubMed ID: 24875077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of clonidine in detoxification from opiates.
    Kleber HD; Gold MS; Riordan CE
    Bull Narc; 1980; 32(2):1-10. PubMed ID: 6907020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of patients with moderately severe methadone dependence onto buprenorphine.
    Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
    Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
    Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
    N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contingent methadone dose increases as a method for reducing illicit opiate use in detoxification patients.
    Higgins ST; Stitzer ML; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984; 55():178-84. PubMed ID: 6443376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.